Delivery Order SPE2DB22D3501-SPE2DB25FXG45
- Not listed
- The Defense Logistics Agency awarded a $1,698.21 delivery order to AmerisourceBergen Drug Corp for Duloxetine HCL DR 40 mg capsules (30-count units) on September 9, 2025, with completion targeted for September 10, 2025. This non-competitive, firm fixed-price delivery order was executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of 1,000 units of Duloxetine HCL DR 60 mg capsules at a ceiling value of $1,433.94. This is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,244.93 to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL DR 60 mg capsules (1,000 units). This competitively awarded, firm fixed-price delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Duloxetine is a serotonin-norepinephrine reuptake...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,434.93 to AmerisourceBergen Drug Corp for 1,000 units of Duloxetine HCL DR 60 mg capsules, with an ultimate completion date of August 20, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- This delivery order, awarded on August 28, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, provides 1,000 capsules of Duloxetine HCl 60 mg under a firm fixed-price contract valued at $2,247.82. The order will be completed by August 29, 2025, and performed at the contractor's Conshohocken, Pennsylvania facility. This award represents a non-competitive delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $8,659.63 to AmerisourceBergen Drug Corp for 1,000 capsules of Duloxetine HCL DR 60 mg, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued on August 29, 2025, was not set-aside and represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,674.67 firm fixed-price delivery order is for the supply of 4,564,690 units of Duloxetine HCL DR 40 mg capsules. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- The Defense Logistics Agency awarded a delivery order valued at $3,376.36 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count units). This contract utilizes a firm fixed-price structure and is not set aside for any particular business category. The award is classified as a delivery order, indicating it derives from an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $3,022.92 for 1,000 capsules of Duloxetine HCL DR 60 mg. The award, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, carries a firm fixed price and was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,129.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count units). This is a non-set-aside award with a completion date of September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as a prime...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXG45Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,431.02 to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL DR 40 mg capsules (30-count) with an ultimate completion date of September 11, 2025. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's DLA Troop Support Medical contract serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for the antidepressant medication Duloxetine represents a routine fulfillment under this expansive pharmaceutical prime vendor agreement, demonstrating the company's ongoing capability to meet federal medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/10/25 |